Association Between Anti-cyclic Citrullinated Protein Antibodies and Extra-articular Manifestations in Rheumatoid Arthritis
- 23 October 2026
- journal article
- research article
- Published by SAGE Publications in Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders
- Vol. 19
Abstract
Background: Anti-cyclic citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) are established serological markers in rheumatoid arthritis (RA). However, their specific roles in the development of extra-articular manifestations (EAMs) remain a subject of debate. Objectives: This study aimed to quantitatively evaluate ACPA and RF titers and determine their predictive value for specific EAMs, particularly rheumatoid vasculitis (RV) and interstitial lung disease (ILD). Design: This research was designed as a retrospective cross-sectional study. Methods: We analyzed clinical data from 205 patients with RA, categorized into an RA control group (n = 129) and an RA-EAM group (n = 76). Serum ACPA and RF titers were measured using a second-generation chemiluminescent enzyme immunoassay. To validate the findings, a post hoc power analysis was conducted. Receiver operating characteristic (ROC) curves were generated to determine optimal ACPA cutoff values for predicting RV and ILD. Results: Serum ACPA titers, but not RF titers, were significantly elevated in patients with ILD and RV compared with those without EAMs ( P < .01). To evaluate the diagnostic utility of serum ACPA titers, ROC curve analysis was performed. Receiver operating characteristic curve analysis showed that ACPA had moderate discriminative ability for identifying RV (AUC = 0.755; 95% CI, 0.61-0.88). The optimal cutoff determined by Youden’s index was 120 U/mL (sensitivity 90.0%, specificity 59.7%). For ILD, the AUC was 0.693 (95% CI, 0.59-0.78), with an optimal cutoff value of 42 U/mL (sensitivity 85.0%, specificity 46.5%). ACPA levels in patients with other EAMs did not differ significantly from controls. Conclusion: Our results demonstrated that serum ACPA levels were significantly higher in patients with RA-associated ILD and RV compared with those without systemic involvement. Notably, this association was not observed for RF titers. These findings suggest that high-titer ACPAs may serve as a more specific immunological marker for these severe complications than traditional RF. Registration: Not applicable.Keywords
This publication has 27 references indexed in Scilit:
- Beyond the joints, the extra-articular manifestations in rheumatoid arthritisAutoimmunity Reviews, 2021
- ACPA-positive versus ACPA-negative rheumatoid arthritis: two distinct erosive disease entities on radiography and ultrasonographyRheumatology International, 2019
- Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destructionNature Reviews Rheumatology, 2018
- Anti–citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritisArthritis Care & Research, 2009
- Citrullination in extra-articular manifestations of rheumatoid arthritisRheumatology, 2007
- Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitisArthritis & Rheumatism, 2006
- Regulation of anti–cyclic citrullinated peptide antibodies in rheumatoid arthritis: Contrasting effects of HLA–DR3 and the shared epitope allelesArthritis & Rheumatism, 2005
- Increased endothelial expression of HLA-DQ and interleukin 1alpha in extra-articular rheumatoid arthritis. Results from immunohistochemical studies of skeletal muscleRheumatology, 2001
- Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis: Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expressionArthritis & Rheumatism, 1990
- Immune complexes in sera from patients with rheumatoid vasculitis induce polymorphonuclear cell-mediated injury to endothelial cellsClinical Immunology and Immunopathology, 1988